Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma

Ahmedzai, S.H., Snowden, J.A. orcid.org/0000-0001-6819-3476, Ashcroft, A.J. et al. (19 more authors) (2019) Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
  • Ahmedzai, S.H.
  • Snowden, J.A. https://orcid.org/0000-0001-6819-3476
  • Ashcroft, A.J.
  • Cairns, D.A.
  • Williams, C.
  • Hockaday, A.
  • Cavenagh, J.D.
  • Ademokun, D.
  • Tholouli, E.
  • Allotey, D.
  • Dhanapal, V.
  • Jenner, M.
  • Yong, K.
  • Cavet, J.
  • Hunter, H.
  • Bird, J.M.
  • Pratt, G.
  • Parrish, C.
  • Brown, J.M.
  • Morris, T.C.M.
  • Cook, G.
  • National Cancer Research Institute Haemato-Oncology Clinical Stu, NCRIHOCSG
Copyright, Publisher and Additional Information: © 2019 by American Society of Clinical Oncology. Licensed under the Creative Commons Attribution 4.0 License. https://creativecommons.org/licenses/by/4.0/
Dates:
  • Accepted: 26 February 2019
  • Published (online): 10 April 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 15 Apr 2019 13:34
Last Modified: 18 Apr 2019 05:05
Status: Published online
Publisher: American Society of Clinical Oncology
Refereed: Yes
Identification Number: https://doi.org/10.1200/JCO.18.01006
Related URLs:

Share / Export

Statistics